Huaxi Bio 58.77(1.01)_Stock Quote_Sina Finance_Sina
DATE:  Apr 25 2024

Shanghai Composite Index: 3052.90+0.27% 315.798 billion Yuan

Shenzhen Composite Index: 9264.48+0.14% 458.498 billion yuan

IF0:3533.40+0.37%

HSI: 17284.54+0.48%

Dow Jones: 38460.92 0.00%

NASDAQ: 15712.75 0.00%

Stoke 50:4913.55 -1.53%

FTSE UK 100:8047.75+0.09%

Nikkei: 37628.48 -2.16%

NYMEX Crude Oil: 82.93+0.15%

COMEX Gold: 2329.45 -0.38%

COMEX Silver: 27.25 -0.34%

LME Copper: 9916.15+1.46%

Recent Visits

Name Price (CNY)

The following are the hot stocks

4.72 0.00%

4.32 0.93%

4.84 0.00%

11.33 1.61%

38.95 0.21%

208.94 0.73%

41.06 1.13%

1693.04 -0.03%

11.69 0.34%

28.54 3.14%

12.35 -0.80%

9.85 -1.30%

To view your stock selection, please log in first

Name Price (CNY)

Add Reminder

huaxi biology (688363.SH) ask shares

0.59

+1.01%

58.77

Limit: 69.82

Limit: 46.54

Suspension

2024-04-25 15:00:00

Temporary suspension

28.308 billion -->

Open today:58.10 Volume: 12700 Hands Amplitude:2.29%
Highest:59.18 Turnover: 74.5991 million yuan Exchange rate:0.64%
Minimum:57.85 Total Market Capitalization: 28.308 billion Price-to-Book Ratio:4.09
Yesterday:58.18 Circulation value: 11.647 billion P/E TTM:35.04
Total equity: 0.482 billion Shares outstanding: 0.198 billion

Issued share capital: 49.5626 million Registered capital: 0.482 billion Same share and same right: yes

other industries +0.31 leading shares: vinegar shares 12.76+10.00

Timeshare

Day K

Week K

Month K

K line

Re-weighted K line

Technical diagram

Time-sharing 5-day year line

No reinstatement

Previous reinstatement

Post-reinstatement

B/S point day K

No reinstatement

Previous reinstatement

Post-reinstatement

Week K

No reinstatement

Previous reinstatement

Post-reinstatement

Month K

No reinstatement

Previous reinstatement

Post-reinstatement

Year K

No reinstatement

Previous reinstatement

Post-reinstatement

5 points

15 min 30 min 60 min

2024/04/25/4 15:00 price 58.77 58.78 110 1.01%

▲ ▼ No quantitative ratio MACDBOLLRSIBBIBOLL

Trend comparison:

At the same time:

Aimei Ke (293.18 1.85% Join Trend Comparison)

Tiger Medicine (53.01 0.78% Added Trend Comparison)

kailaiying (76.86 -0.59 added trend comparison)

kang long into a (18.24 0.39 added trend comparison)

beitani (57.51 -0.95 added trend comparison)

Cobos (42.40 1.44% added trend comparison)

haohai biological department (92.62 -0.37 joining trend comparison)

stone technology (373.79 -2.81 added trend comparison)

medisi (32.69 0.71% added trend comparison)

Five-gear plate opening

Master Live

Commission ratio 67.63% 241

Sell ⑤58.878
Sell ④58.857
Sell ③58.842
Sell ②58.8328
Sell ①58.8213
Done 58.77
Buy ①58.77196
Buy ②58.724
Buy ③58.6854
Buy ④58.672
Buy ⑤58.6643

External disk 6485

Internal 6205

there is a key big order, the main force or in **

Timeshare

Quantity (-->

Time Price (Yuan) quantity (hand) Properties
15:00:0058.77110 neutral disk
14:56:5558.664 sell
14:56:5258.662 sell
14:56:4058.726 sell
14:56:3158.8214 Buy
14:56:2258.82 4 Buy
14:56:1958.737 sell
14:56:1358.823 Buy
14:56:1058.822 Buy
14:56:0758.7910 neutral disk
14:56:0458.804 sell

Scan code subscription

Investment Report

retail sell retail buy main sell main buy

main buy main sell retail buy retail sell

Amount ($million) 1352.92 1021.16 2144.85 2474.09

proportion 18.13% 13.69% 28.75% 33.16% bulk single small single large single extra large single

loose orders, small orders, large orders, large orders, large orders

Net inflow ($million) 137.42 -466.66 88.72 243.04

0.17% 0.26% 0.20% 0.02%

25.87% 40.00% 30.87% 3.26%

feichao new material IPO: research and development costs continue to surge "step on the line to meet the standards" customer related parties through private placement low price surprise stake in scientific research attribute

2024-04-23 16:10:51

Product: Sina Finance Listed Company Research Institute Author: IPO Refinancing Group/Zheng Quan Recently, the CSRC intends to revise the evaluation index of the science and technology attributes, aiming to adhere to the functional positioning of the plate, highlight the "hard technology" characteristics of the science and technology board, and strengthen the requirements of the science and technology attributes. There are three main contents to be revised in the draft of the "Guidelines for the Evaluation of the Attributes of Science and Technology Innovation (Trial)". One is that the last three years...

Keming Foods lowers the amount of funds raised to help the real controller? The main business is lost and the real controller's family's pig farming assets are "thunderstorms"

2024-04-11 17:51:12

Produced by: Sina Finance Listed Company Research Institute Author: Langtou Diet/Hao Xian Recently, as the share price fell sharply, Keming Foods significantly reduced the number of fixed issuance. In the case of the stock price and the issue price upside down for the real controller family "out of the way". Since mid-January this year, Keming Food's share price has fallen by nearly 20%, and its current valuation is only 1.09 times PB. The company...

the amount of venture capital in March fell by more than 40% year-on-year: Dalian Wanda business management was invested in 60 billion CDH's first real estate fund

2024-04-09 17:52:36

Production: Edited by Sina Finance Listed Company Research Institute: shu China's private equity investment market ushered in the largest single investment in the past five years. According to public reports, on March 30, Dalian Wanda Business Management and PAG Pacific Alliance Group, Ares Management, and Invest, Abu Dhabi sovereign wealth fund Mubadala, UAE...

Zhongxin Airlines net profit halved radical expansion consequences show that the main customer sales collective weak market share or will continue to decline

2024-04-09 17:52:36

Production: Sina Finance Listed Company Research Institute Author: Hao Recently, Zhongchong Xinhang released its annual report showing that in 2023, the company achieved operating income of 27.006 billion yuan, up 32.5 percent year-on-year, and net profit of 0.294 billion yuan, down 57.44 percent year-on-year. In contrast, Ningde's revenue and net profit growth during the same period were 22% and 44%, respectively. phase...

feichao new material IPO: research and development costs continue to surge "step on the line to meet the standards" customer related parties through private placement low price surprise stake in scientific research attribute

2024-04-23 16:10:51

Product: Sina Finance Listed Company Research Institute Author: IPO Refinancing Group/Zheng Quan Recently, the CSRC intends to revise the evaluation index of the science and technology attributes, aiming to adhere to the functional positioning of the plate, highlight the "hard technology" characteristics of the science and technology board, and strengthen the requirements of the science and technology attributes. There are three main contents to be revised in the draft of the "Guidelines for the Evaluation of the Attributes of Science and Technology Innovation (Trial)". One is that the last three years...

Keming Foods lowers the amount of funds raised to help the real controller? The main business is lost and the real controller's family's pig farming assets are "thunderstorms"

2024-04-11 17:51:12

Produced by: Sina Finance Listed Company Research Institute Author: Langtou Diet/Hao Xian Recently, as the share price fell sharply, Keming Foods significantly reduced the number of fixed issuance. In the case of the stock price and the issue price upside down for the real controller family "out of the way". Since mid-January this year, Keming Food's share price has fallen by nearly 20%, and its current valuation is only 1.09 times PB. The company...

the amount of venture capital in March fell by more than 40% year-on-year: Dalian Wanda business management was invested in 60 billion CDH's first real estate fund

2024-04-09 17:52:36

Production: Edited by Sina Finance Listed Company Research Institute: shu China's private equity investment market ushered in the largest single investment in the past five years. According to public reports, on March 30, Dalian Wanda Business Management and PAG Pacific Alliance Group, Ares Management, and Invest, Abu Dhabi sovereign wealth fund Mubadala, UAE...

Zhongxin Airlines net profit halved radical expansion consequences show that the main customer sales collective weak market share or will continue to decline

2024-04-09 17:52:36

Production: Sina Finance Listed Company Research Institute Author: Hao Recently, Zhongchong Xinhang released its annual report showing that in 2023, the company achieved operating income of 27.006 billion yuan, up 32.5 percent year-on-year, and net profit of 0.294 billion yuan, down 57.44 percent year-on-year. In contrast, Ningde's revenue and net profit growth during the same period were 22% and 44%, respectively. phase...

Follow the public number to view the full text

Corporate Capital

Sweep and pay attention to me

Company Research

hot data more main business income (billion yuan)

Adjacent rank

Top 10

2023-09 huaxi biological main business income (billion yuan) industry ranked first (4)

Huaxi Bio Meike * ST Meigu Jinbo Bio 01020304050

Financial Ratios More ROE

Adjacent rank

Top 10

2023-09 huaxi biological return on net assets industry ranked 3rd (4th)

Jin Bo Biology Aimei Ke Hua Xi Biology * ST Mei Gu 0612182430

Research Agency Investment Rating More

66 research reports have issued Huaxi Biological (sh688363) ratings in the last 60 days, and the comprehensive ratings are as follows:

Hotspot

Industry Comparison Increase

Name price (yuan) increase (%)

12.76 10.00

12.57 3.63

9.37 3.42

4.29 3.37

2.85 3.26

9.76 3.06

36.09 2.85

7.93 2.59

Company Name:

Huaxi Biotechnology Co., Ltd.

Main Business:

Microbial fermentation and cross-linking two major technology platforms, the development of biological activities that contribute to human life and health...

Tel:0531-82685888

Fax:0531-82685888

Date of Establishment:2000-01-03

Listing Date:2019-11-06

Legal Representative: Zhao Yan

General Manager: Zhao Yan

Registered capital: 481.678 million yuan

Issue price:47.790 yuan

Latest total share capital: 481.678242 million shares

Latest shares outstanding: 10,000 shares

2023-09

2023-06

2023-03

2022-12

2022-09

EPS 1.0679 yuan 0.8815 yuan 0.4164 yuan 2.0182 yuan 1.4081 yuan
Net assets per share 14.3795 yuan 14.2341 yuan 14.2957 yuan 13.7892 yuan 13.0915 yuan
Net operating cash flow per share 0.4876 yuan 0.3870 yuan -0.4119 yuan 1.3203 yuan 0.2421 yuan
ROE 7.43%6.19%2.91%14.64%10.76%
Undistributed profit per share 4.9194 yuan 4.7458 yuan 4.8920 yuan 4.4798 yuan 3.8697 yuan
Capitalization per share 7.9533 yuan 7.9381 yuan 7.8967 yuan 7.8008 yuan 7.7614 yuan

Announcement Date Allocation Scheme
2023-06-1510 6.1 yuan
2022-05-1010 4.9 yuan
2021-07-0910 4.1 yuan
2020-07-1110 3.7 yuan

2023-09

2023-08

2023-06

Name of shareholder Ownership (%) Increase or decrease
Guoshou Chengda (Shanghai...17.375 Unchanged
China Merchants Bank shares have...10.113 Overweight
Beijing Guoshou Taihe Phase I...2.940 Unchanged
Tianjin huajie haihe medical...2.725 Unchanged
Industrial and Commercial Bank of China Stock...2.634 Overweight
WEST SU...2.526 Unchanged
Hong Kong Securities Clearing Company Limited has...2.482 Reduce
bank of China shares have...1.554 Reduce
Fortune...1.508 Unchanged
Ariz (Tianjin)...1.408 Unchanged

Shareholder Name Shareholding (%) Increase or decrease

Guoshou Chengda (Shanghai... 17.375 unchanged

China Merchants Bank shares have... 9.563 increase

Beijing Tonghui Taihe Investment... 2.940 unchanged

Tianjin Huajie Haihe Medical... 2.725 unchanged

Hong Kong Central Clearing has... 2.620 to increase its holdings

WEST SU... 2.526 unchanged

Industrial and Commercial Bank of China shares... 2.517 increase

Bank of China shares have... 1.651 increase

Fortune... 1.508 unchanged

Ariz (Tianjin)... 1.408 unchanged

Shareholder Name Shareholding (%) Increase or decrease

Guoshou Chengda (Shanghai... 17.375 unchanged

China Merchants Bank shares have... 5.869 increase

Beijing Tonghui Taihe Investment... 2.940 New

Tianjin Huajie Haihe Medical... 2.725 Unchanged

Hong Kong Central Clearing has... 2.604 reduction

WEST SU... 2.526 unchanged

Industrial and Commercial Bank of China shares... 1.951 new

Bank of China shares have... 1.589 increase

Fortune... 1.508 unchanged

Ariz (Tianjin)... 1.408 unchanged

Shareholding ratio of outstanding shareholders

Customer service hotline: 4000520066 welcome criticism and correction

frequently asked questions and answers internet illegal and bad information reporting sina financial feedback message board

Sina profile About Sina advertising service contact us recruitment information website lawyer SINA English pass registration product answer

Sina Corporation Copyright Sina Finance provides free stock, fund, bond, foreign exchange and other market data and other materials from relevant partners, only for the purpose of obtaining information for users, and does not constitute investment advice.

Sina Finance and its partners are not responsible for errors, inaccuracies, delays in providing information on this page or for any actions taken in reliance on this information. The market is risky and investment needs to be cautious.

Follow Yicai Global on

star50stocks

Ticker Name

Percentage Change

Inclusion Date